| Enzalutamide in metastatic prostate cancer before chemotherapy TM Beer, AJ Armstrong, DE Rathkopf, Y Loriot, CN Sternberg, CS Higano, ... New England Journal of Medicine 371 (5), 424-433, 2014 | 3338 | 2014 |
| Signaling through the JAK/STAT pathway, recent advances and future challenges T Kisseleva, S Bhattacharya, J Braunstein, CW Schindler Gene 285 (1-2), 1-24, 2002 | 1742 | 2002 |
| Phase II pilot study of vemurafenib in patients with metastatic BRAF-mutated colorectal cancer S Kopetz, J Desai, E Chan, JR Hecht, PJ O'Dwyer, D Maru, V Morris, ... Journal of clinical oncology 33 (34), 4032, 2015 | 734 | 2015 |
| Independent review of E2100: a phase III trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancer R Gray, S Bhattacharya, C Bowden, K Miller, RL Comis Journal of Clinical Oncology 27 (30), 4966, 2009 | 394 | 2009 |
| Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study ND Shore, S Chowdhury, A Villers, L Klotz, DR Siemens, D Phung, ... The Lancet Oncology 17 (2), 153-163, 2016 | 291 | 2016 |
| Adaptive seamless phase II/III designs—background, operational aspects, and examples J Maca, S Bhattacharya, V Dragalin, P Gallo, M Krams Drug information journal 40 (4), 463-473, 2006 | 149 | 2006 |
| Comparison of an exact and an approximate method of singularity avoidance in platform type parallel manipulators S Bhattacharya, H Hatwal, A Ghosh Mechanism and Machine Theory 33 (7), 965-974, 1998 | 145 | 1998 |
| PREVAIL Investigators: Enzalutamide in metastatic prostate cancer before chemotherapy TM Beer, AJ Armstrong, DE Rathkopf, Y Loriot, CN Sternberg, CS Higano, ... N Engl J Med 371 (5), 424-433, 2014 | 142 | 2014 |
| Enzalutamide in men with chemotherapy-naive metastatic prostate cancer (mCRPC): Results of phase III PREVAIL study. TM Beer, AJ Armstrong, CN Sternberg, CS Higano, P Iversen, Y Loriot, ... Journal of Clinical Oncology 32 (4_suppl), LBA1-LBA1, 2014 | 111 | 2014 |
| Composite magnetic particles: 2. Encapsulation of iron oxide by surfactant-free emulsion polymerization A Pich, S Bhattacharya, A Ghosh, HJP Adler Polymer 46 (13), 4596-4603, 2005 | 108 | 2005 |
| The PREVAIL study: primary outcomes by site and extent of baseline disease for enzalutamide-treated men with chemotherapy-naive metastatic castration-resistant prostate cancer CP Evans, CS Higano, T Keane, G Andriole, F Saad, P Iversen, K Miller, ... European urology 70 (4), 675-683, 2016 | 99 | 2016 |
| International design study for the neutrino factory, interim design report S Choubey, G Rees, VB Graves, L Tortora, O Yasuda, T Li, D Stratakis, ... | 90 | 2011 |
| Magnetorheology of synthesized core-shell structured nanoparticle HJ Choi, IB Jang, JY Lee, A Pich, S Bhattacharya, HJ Adler IEEE transactions on magnetics 41 (10), 3448-3450, 2005 | 80 | 2005 |
| Comparison of Subgroup Analyses of PFS from Three Phase III Studies of Bevacizumab in Combination with Chemotherapy in Patients with HER2-Negative Metastatic Breast Cancer (MBC). J O'Shaughnessy, V Dieras, J Glaspy, A Brufsky, K Miller, D Miles, ... Cancer Research 69 (24_Supplement), 207-207, 2009 | 70 | 2009 |
| Knowledge dilemmas within organizations: Resolutions from game theory RS Sharma, S Bhattacharya Knowledge-Based Systems 45, 100-113, 2013 | 58 | 2013 |
| Composite magnetic particles: 1. Deposition of magnetite by heterocoagulation method A Pich, S Bhattacharya, HJP Adler Polymer 46 (4), 1077-1086, 2005 | 56 | 2005 |
| Radiographic progression-free survival as a clinically meaningful end point in metastatic castration-resistant prostate cancer: the PREVAIL randomized clinical trial DE Rathkopf, TM Beer, Y Loriot, CS Higano, AJ Armstrong, CN Sternberg, ... JAMA oncology 4 (5), 694-701, 2018 | 53 | 2018 |
| Role of sensitivity analyses in assessing progression-free survival in late-stage oncology trials S Bhattacharya, G Fyfe, RJ Gray, DJ Sargent Journal of clinical oncology 27 (35), 5958-5964, 2009 | 45 | 2009 |
| Thyrotoxicity of the chlorides of cadmium and mercury in rabbit. N Ghosh, S Bhattacharya Biomedical and Environmental Sciences: BES 5 (3), 236-240, 1992 | 41 | 1992 |
| Sensitization of cisplatin therapy by a naphthalimide based organoselenium compound through modulation of antioxidant enzymes and p53 mediated apoptosis P Ghosh, S Singha Roy, A Basu, A Bhattacharjee, S Bhattacharya Free Radical Research 49 (4), 453-471, 2015 | 38 | 2015 |
